Serum amyloid a regulates granulomatous inflammation in sarcoidosis through toll-like receptor-2

American Journal of Respiratory and Critical Care Medicine

Volumn 181, Issue 4, 2010, Pages 360-373

  Chen, Edward S ^a   Song, Zhimin ^a   Willett, Matthew H ^a   Heine, Shannon ^a   Yung, Rex C ^a   Liu, Mark C ^a   Groshong, Steve D ^b   Zhang, Ying ^c   Tuder, Rubin M ^b   Moller, David R ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Cytokines; Granuloma; Innate immunity; Sarcoidosis; Serum amyloid A

Indexed keywords

AMYLOID A PROTEIN; CATALASE; CD68 ANTIGEN; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 18; PEROXIDASE; SERUM AMYLOID A; TOLL LIKE RECEPTOR 2; TUMOR NECROSIS FACTOR;

ANIMAL EXPERIMENT; ARTICLE; BLOOD SAMPLING; CD3+ T LYMPHOCYTE; CELL STRAIN HEK293; CELLULAR DISTRIBUTION; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GIANT CELL; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INNATE IMMUNITY; MACROPHAGE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SARCOIDOSIS; TH1 CELL;

ADULT; ANIMALS; CELLS, CULTURED; DISEASE MODELS, ANIMAL; FEMALE; FLOW CYTOMETRY; GRANULOMA; HUMANS; LUNG; MALE; MICE; MIDDLE AGED; NF-KAPPA B; PNEUMONIA; RATS; SARCOIDOSIS, PULMONARY; SERUM AMYLOID A PROTEIN; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 2;

EID: 76149085179     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.200905-0696OC     Document Type: Article

References (50)

1. American Thoracic Society (ATS), European Respiratory Society (ERS), World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG). Statement on sarcoidosis. Am J Respir Crit Care Med 1999;160:736-755.
2. Iannuzzi MC, Rybicki BA, Teirstein AS. Sarcoidosis. N Engl J Med 2007;357:2153-2165.
3. Zissel G, Prasse A, Muller-Quernheim J. Sarcoidosis: immunopathogenetic concepts. Semin Respir Crit Care Med 2007;28:3-14.
4. Moller DR, Forman JD, Liu MC, Noble PW, Greenlee BM, Vyas P, Holden DA, Forrester JM, Lazarus A, Wysocka M, et al. Enhanced expression of IL-12 associated with Th1 cytokine profiles in active pulmonary sarcoidosis. J Immunol 1996;156:4952-4960.
5. Bachwich PR, Lynch JP III, Larrick J, Spengler M, Kunkel SL. Tumor necrosis factor production by human sarcoid alveolar macrophages. Am J Pathol 1986;125:421-425.
6. Greene CM, Meachery G, Taggart CC, Rooney CP, Coakley R, O'Neill SJ, McElvaney NG. Role of IL-18 in CD41 T lymphocyte activation in sarcoidosis. J Immunol 2000;165:4718-4724.
7. Bingisser R, Speich R, Zollinger A, Russi E, Frei K. Interleukin-10 secretion by alveolar macrophages and monocytes in sarcoidosis. Respiration 2000;67:280-286.
8. Song Z, Marzilli L, Greenlee BM, Chen ES, Silver RF, Askin FB, Teirstein AS, Zhang Y, Cotter RJ, Moller DR. Mycobacterial catalase-peroxidase is a tissue antigen and target of the adaptive immune response in systemic sarcoidosis. J Exp Med 2005;201:755-767.
9. Chen ES, Wahlstrom J, Song Z, Willett MH, Wiken M, Yung RC, West EE, McDyer JF, Zhang Y, Eklund A, et al. T cell responses to mycobacterial catalase-peroxidase profile a pathogenic antigen in systemic sarcoidosis. J Immunol 2008;181:8784-8796.
10. Drake WP, Dhason MS, Nadaf M, Shepherd BE, Vadivelu S, Hajizadeh R, Newman LS, Kalams SA. Cellular recognition of mycobacterium tuberculosis ESAT-6 and KatG peptides in systemic sarcoidosis. Infect Immun 2007;75:527-530.
11. Dubaniewicz A, Trzonkowski P, Dubaniewicz-Wybieralska M, Singh M, Mysliwski A. Mycobacterial heat shock protein-induced blood T lymphocytes subsets and cytokine pattern: comparison of sarcoidosis with tuberculosis and healthy controls. Respirology 2007;12:346-354.
12. Munro CS, Mitchell DN. The Kveim response: still useful, still a puzzle. Thorax 1987;42:321-331.
13. Klein JT, Horn TD, Forman JD, Silver RF, Teirstein AS, Moller DR. Selection of oligoclonal V beta-specific T cells in the intradermal response to Kveim-Siltzbach reagent in individuals with sarcoidosis. J Immunol 1995;154:1450-1460.
14. Lyons DJ, Donald S, Mitchell DN, Asherson GL. Chemical inactivation of the Kveim reagent. Respiration 1992;59:22-26.
15. Uhlar CM, Whitehead AS. Serum amyloid A, the major vertebrate acute-phase reactant. Eur J Biochem 1999;265:501-523.
16. Chen ES, Willett MH, Song Z, Zhang Y, Moller DR. Regulation of granulomatous inflammation by the receptor for advanced glycation end-products in an experimental model of sarcoidosis [abstract]. Am J Respir Crit Care Med 2008;177:A353.
17. Petrache I, Natarajan V, Zhen L, Medler TR, Richter AT, Cho C, Hubbard WC, Berdyshev EV, Tuder RM. Ceramide upregulation causes pulmonary cell apoptosis and emphysema-like disease in mice. Nat Med 2005;11:491-498.
18. Sonnenberg MG, Belisle JT. Definition of Mycobacterium tuberculosis culture filtrate proteins by two-dimensional polyacrylamide gel electrophoresis, N-terminal amino acid sequencing, and electrospray mass spectrometry. Infect Immun 1997;65:4515-4524.
19. Zhang Y, Heym B, Allen B, Young D, Cole S. The catalase-peroxidase gene and isoniazid resistance of Mycobacterium tuberculosis. Nature 1992;358:591-593.
20. Wynn TA, Eltoum I, Oswald IP, Cheever AW, Sher A. Endogenous interleukin 12 (IL-12) regulates granuloma formation induced by eggs of Schistosoma mansoni and exogenous IL-12 both inhibits and prophylactically immunizes against egg pathology. J Exp Med 1994; 179:1551-1561.
21. Chensue SW, Warmington K, Ruth J, Lincoln P, Kuo MC, Kunkel SL. Cytokine responses during mycobacterial and schistosomal antigen-induced pulmonary granuloma formation: production of Th1 and Th2 cytokines and relative contribution of tumor necrosis factor. Am J Pathol 1994;145:1105-1113.
22. Cheng N, He R, Tian J, Ye PP, Ye RD. Cutting edge: TLR2 is a functional receptor for acute-phase serum amyloid A. J Immunol 2008;181:22-26.
23. Rothkrantz-Kos S, van Dieijen-Visser MP, Mulder PG, Drent M. Potential usefulness of inflammatory markers to monitor respiratory functional impairment in sarcoidosis. Clin Chem 2003;49:1510-1517.
24. Thorns CJ, Morris JA, Little TW. A spectrum of immune responses and pathological conditions between certain animal species to experimental Mycobacterium bovis infection. Br J Exp Pathol 1982;63: 562-572.
25. Smith FB, Brown RB, Maguire G, Oliver J. Localized pleural micro-deposition of type A amyloid in a patient with rheumatoid pleuritis: histologic distinction from pleural involvement in systemic amyloidosis. Am J Clin Pathol 1993;99:261-264.
26. Ham D, Caouras V, Radzioch D, Gervais F. Degradation of amyloid A precursor protein SAA by macrophage cell lines obtained from amyloid resistant and susceptible strains of mice. Scand J Immunol 1997;45:354-360.
27. Kosma VM, Collan Y, Kulju T, Aalto ML, Jantunen E, Karhunen J, Selkainaho K. Reproducibility of morphometric measurements of amyloid after various staining methods. Anal Quant Cytol Histol 1985; 7:267-270.
28. Kitamoto T, Ogomori K, Tateishi J, Prusiner SB. Formic acid pretreatment enhances immunostaining of cerebral and systemic amyloids. Lab Invest 1987;57:230-236.
29. Sharma OP, Koss M, Buck F. Sarcoidosis and amyloidosis: is the association causal or co-incidental? Sarcoidosis 1987;4:139-141.
30. Lundmark K, Westermark GT, Olsen A, Westermark P. Protein fibrils in nature can enhance amyloid protein A amyloidosis in mice: cross-seeding as a disease mechanism. Proc Natl Acad Sci USA 2005;102: 6098-6102.
31. Ehrt S, Schnappinger D, Bekiranov S, Drenkow J, Shi S, Gingeras TR, Gaasterland T, Schoolnik G, Nathan C. Reprogramming of the macrophage transcriptome in response to interferon-γ and Mycobacterium tuberculosis: signaling roles of nitric oxide synthase-2 and phagocyte oxidase. J Exp Med 2001;194:1123-1140.
32. Preciado-Patt L, Levartowsky D, Prass M, Hershkoviz R, Lider O, Fridkin M. Inhibition of cell adhesion to glycoproteins of the extracellular matrix by peptides corresponding to serum amyloid A: toward understanding the physiological role of an enigmatic protein. Eur J Biochem 1994;223:35-42.
33. Cosma CL, Humbert O, Ramakrishnan L. Superinfecting mycobacteria home to established tuberculous granulomas. Nat Immunol 2004;5: 828-835.
34. Heikenwalder M, Kurrer MO, Margalith I, Kranich J, Zeller N, Haybaeck J, Polymenidou M, Matter M, Bremer J, Jackson WS, et al. Lymphotoxin-dependent prion replication in inflammatory stromal cells of granulomas. Immunity 2008;29:998-1008.
35. Preciado-Patt L, Hershkoviz R, Fridkin M, Lider O. Serum amyloid A binds specific extracellular matrix glycoproteins and induces the adhesion of resting CD41 T cells. J Immunol 1996;156:1189-1195.
36. Flynn JL, Goldstein MM, Chan J, Triebold KJ, Pfeffer K, Lowenstein CJ, Schreiber R, Mak TW, Bloom BR. Tumor necrosis factor-a is required in the protective immune response against Mycobacterium tuberculosis in mice. Immunity 1995;2:561-572.
37. Wynn TA, Morawetz R, Scharton-Kersten T, Hieny S, Morse HC III, Kuhn R, Muller W, Cheever AW, Sher A. Analysis of granuloma formation in double cytokine-deficient mice reveals a central role for IL-10 in polarizing both T helper cell 1- and T helper cell 2-type cytokine responses in vivo. J Immunol 1997;159:5014-5023.
38. Jacobs M, Fick L, Allie N, Brown N, Ryffel B. Enhanced immune response in Mycobacterium bovis bacille Calmette Guerin (BCG)-infected IL-10-deficient mice. Clin Chem Lab Med 2002;40:893-902.
39. Migita K, Kawabe Y, Tominaga M, Origuchi T, Aoyagi T, Eguchi K. Serum amyloid A protein induces production of matrix metalloproteinases by human synovial fibroblasts. Lab Invest 1998;78:535-539.
40. Cai H, Song C, Endoh I, Goyette J, Jessup W, Freedman SB, McNeil HP, Geczy CL. Serum amyloid A induces monocyte tissue factor. J Immunol 2007;178:1852-1860.
41. Patel H, Fellowes R, Coade S, Woo P. Human serum amyloid A has cytokine-like properties. Scand J Immunol 1998;48:410-418.
42. He RL, Zhou J, Hanson CZ, Chen J, Cheng N, Ye RD. Serum amyloid A induces G-CSF expression and neutrophilia via Toll-like receptor 2. Blood 2009;113:429-437.
43. Lane AP, Truong-Tran QA, Myers A, Bickel C, Schleimer RP. Serum amyloid A, properdin, complement 3, and Toll-like receptors are expressed locally in human sinonasal tissue. Am J Rhinol 2006;20:117-123.
44. Veltkamp M, Wijnen PA, van Moorsel CH, Rijkers GT, Ruven HJ, Heron M, Bekers O, Claessen AM, Drent M, van den Bosch JM, et al. Linkage between Toll-like receptor (TLR) 2 promoter and intron polymorphisms: functional effects and relevance to sarcoidosis. Clin Exp Immunol 2007;149:453-462.
45. Wiken M, Grunewald J, Eklund A, Wahlstrom J. Higher monocyte expression of TLR2 and TLR4, and enhanced pro-inflammatory synergy of TLR2 with NOD2 stimulation in sarcoidosis. J Clin Immunol 2009;29:78-79.
46. Sieling PA, Chung W, Duong BT, Godowski PJ, Modlin RL. Toll-like receptor 2 ligands as adjuvants for human Th1 responses. J Immunol 2003;170:194-200.
47. Re F, Strominger JL. IL-10 released by concomitant TLR2 stimulation blocks the induction of a subset of Th1 cytokines that are specifically induced by TLR4 or TLR3 in human dendritic cells. J Immunol 2004; 173:7548-7555.
48. Campo I, Morbini P, Zorzetto M, Tinelli C, Brunetta E, Villa C, Bombieri C, Cuccia M, Agostini C, Bozzi V, et al. Expression of receptor for advanced glycation end products in sarcoid granulomas. Am J Respir Crit Care Med 2007;175:498-506.
49. Yan SD, Zhu H, Zhu A, Golabek A, Du H, Roher A, Yu J, Soto C, Schmidt AM, Stern D, et al. Receptor-dependent cell stress and amyloid accumulation in systemic amyloidosis. Nat Med 2000;6:643-651.
50. de Beer FC, Nel AE, Gie RP, Donald PR, Strachan AF. Serum amyloid A protein and C-reactive protein levels in pulmonary tuberculosis: relationship to amyloidosis. Thorax 1984;39:196-200.